Advanced

Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study

Axmon, A. LU ; Kristensson, J. LU ; Midlöv, P. LU ; Karlsson, B. and Ahlström, G. LU (2016) 2016 IASSIDD World Congress In Journal of Intellectual Disability Research 60(7-8). p.632-632
Abstract
Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but... (More)
Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
acetylcholinesterase, benzodiazepine derivative, neuroleptic agent, dementia, health care utilization, hospital, human, human tissue, major clinical study, population, register
in
Journal of Intellectual Disability Research
volume
60
issue
7-8
pages
1 pages
publisher
Federation of European Neuroscience Societies and Blackwell Publishing Ltd
conference name
2016 IASSIDD World Congress
ISSN
0964-2633
DOI
10.1111/jir.12305
language
English
LU publication?
yes
id
3ee4ce66-d128-4718-b5fc-b2f14ab4ca4d
date added to LUP
2016-08-25 14:39:18
date last changed
2016-11-15 14:59:13
@misc{3ee4ce66-d128-4718-b5fc-b2f14ab4ca4d,
  abstract     = {Aim: To describe drug use and healthcare utilisation among persons with intellectual disabilities (ID) and dementia in comparison to persons with ID only and dementia only. Method: From the group of persons with ID (n=7936), 216 individuals with dementia were identified. 81 persons with dementia were identified from a general population sample matched by age and sex. Information on outcomes was collected retrospectively from national registries. Healthcare utilisation was measured as the number of hospital visits and the number of hospitalisations. Drug use was assessed for antipsychotics, benzodiazepine derivatives, and anticholinesterases. Results: Persons with ID and dementia had higher healthcare utilisation than persons with ID but without dementia, but similar levels as persons with dementia in the general population sample. They were more likely to use antipsychotics and less likely to use anticholinesterases than persons with dementia but without ID. Conclusions: Dementia in persons with ID seems to increase healthcare utilisation and drug use. However, with respect to healthcare utilisation, the levels do not exceed those found among persons with dementia in the general population.},
  author       = {Axmon, A. and Kristensson, J. and Midlöv, P. and Karlsson, B. and Ahlström, G.},
  issn         = {0964-2633},
  keyword      = {acetylcholinesterase,benzodiazepine derivative,neuroleptic agent,dementia,health care utilization,hospital,human,human tissue,major clinical study,population,register},
  language     = {eng},
  month        = {07},
  number       = {7-8},
  pages        = {632--632},
  publisher    = {ARRAY(0xaed8db8)},
  series       = {Journal of Intellectual Disability Research},
  title        = {Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study},
  url          = {http://dx.doi.org/10.1111/jir.12305},
  volume       = {60},
  year         = {2016},
}